ME group (n = 62) | TE group (n = 51) | p | |
---|---|---|---|
Age | 65.9 ± 6.5 | 64.5 ± 5.8 | 0.234 |
Gender (male/female) | 42/20 | 36/15 | 0.745 |
Body mass index (BMI) | 25.3 ± 4.6 | 22.5 ± 5.3 | 0.003* |
Blood gas analysis | |||
PO2 | 81.6 ± 7.6 | 82.6 ± 8.3 | 0.506 |
1PCO2 | 36.4 ± 7.2 | 35.8 ± 8.6 | 0.687 |
Pulmonary function | |||
Vital capacity % | 88.7 ± 13.6 | 86.9 ± 14.7 | 0.501 |
FEV1 % | 79.4 ± 4.2 | 80.8 ± 5.3 | 0.120 |
Blood routine test | |||
White blood cell (102/mm3) | 57.5 ± 10.8 | 60.5 ± 11.4 | 0.155 |
Neutrophil (%) | 71.5 ± 7.8 | 72.6 ± 8.5 | 0.475 |
Hemoglobin (g/L) | 121.5 ± 19.4 | 119.4 ± 22.7 | 0.597 |
Albumin (g/L) | 34.5 ± 4.3 | 33.9 ± 4.6 | 0.476 |
History of smoke | 35 (56.5 %) | 26 (51.0 %) | 0.561 |
History of ethanol | 23 (37.1 %) | 12 (23.5 %) | 0.121 |
Prior gastric or esophageal surgery | 2 (3.2 %) | 0 (0 %) | 0.196 |
Previous chest surgery | 1 (1.6 %) | 0 (0 %) | 0.362 |
Comorbidities | |||
Coronary artery disease | 5 (8.1 %) | 2 (3.9 %) | 0.363 |
Diabetes mellitus | 6 (9.7 %) | 7 (13.7 %) | 0.502 |
COPD/emphysema | 4 (6.5 %) | 1 (2.0 %) | 0.248 |
ASA grade | 0.793 | ||
I | 12 (19.4 %) | 11 (21.6 %) | |
II | 40 (64.5 %) | 34 (66.7 %) | |
III | 10 (16.1 %) | 6 (11.8 %) |